Stay updated on Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded 'Revision: v3.4.3' and removed 'Revision: v3.4.2'. No other page content was altered.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.2 is now shown on the page, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.1 has been added, and the funding-lapse notice regarding government status has been removed.SummaryDifference0.1%

- Check83 days agoChange DetectedA site-wide notice about a lapse in government funding and that the NIH Clinical Center is open has been added, with a link to opm.gov for status updates.SummaryDifference0.1%

Stay in the know with updates to Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety/Efficacy of Nemolizumab in Atopic Dermatitis Clinical Trial page.